Product Detail

• Describe the four classes of cardiac medications and their effects on the function of the cardiac cycle.
• Explain the effects that each class of cardiac medications has on the cardiac cycle.
• Identify the classes of medications used to treat acute coronary syndrome.
• Discriminate between the treatments for ischemic and hemorrhagic stroke.
• Explain the benefits of medications used to treat metabolic syndrome and dyslipidemia.
• Analyze the benefits and risks of medications used to treat heart failure.
• Define the criteria used to initiate antihypertensive medications after lifestyle modifications have been employed.
• Recognize dangerous drug-drug interactions of cardiac and non-cardiac medications.

Cardiac Hemodynamics: Beyond Blood Pressure and Heart Rate

• Preload
• Afterload
• Contractility
• Normal and abnormal electrocardiographic tracings

Antiarrhythmic Agents: Avoid the 3 Most Common Mistakes

• Class I agents (sodium channel blockers)
• Class II agents (beta-blockers)
• Class III agents (potassium channel blockers)
• Class IV agents (calcium channel blockers)
• AHA/ACC Anticoagulant Administration Guidelines
• Nitrates
• Aspirin
• Morphine sulfate
• Beta blockers
• Fibrinolytic agents
• Antiplatelet agents
• Anticoagulants
• ACE inhibitors
• Angiotensin receptor blockers (ARB)

Stroke Patients: Avoid 4 Common Medication Errors

• Ischemic
• Hypertension: Labetalol, Nitropaste, Nicardipine
• Hypotension: Crystalloid, Dopamine
• Thrombolytic agents
• Antiepileptic medications
• Dabigatran
• Hemorrhagic
• Correct coagulation abnormalities
• Glucose management
• Blood pressure control
• Antiepileptic medications

Metabolic Syndrome and Dyslipidemia Patients: Medications that Should NOT Be Administered Together

• NCEP ATPIII guidelines
• Lipid modifying medications
• Statins
• Fibrates
• Resins
• Niacin
• Blood glucose control
• Insulin
• Oral agents

Congestive Heart Failure: Medications to Start and Avoid Based Upon Patient Presentation Digoxin

• Nesiritide
• Diuretics
• ACE inhibitors
• ARB
• Aldosterone antagonists
• Beta-blockers

WARNING: What the Antihypertensive Therapy Guidelines Do Not Specify

• Diuretics
• Loop
• Thiazide
• Potassium-sparing
• ACE inhibitors
• ARB
• Beta-blockers
• Calcium channel blockers
• Alpha blocking agents
• Vasodilators
• Lifestyle modifications

Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists and physicians.

Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of the infectious disease and multi-system organ failure patient.

His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every education program. Speaker Disclosures:
Financial: Paul Langlois has employment relationships with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Paul Langlois is a member of the American Nurses Association and the American Association of Critical Care Nurses.

Save time and $10 off the price of other submission methods – purchase & take the CE test online for $9.99 USD per participant. Additional processing fees apply for other submission methods (i.e. mail, fax, etc.). Please contact our Customer Service at 1-800-844-8260 for more details.

Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self study is an acceptable form of continuing education. Please refer to your state rules and regulations.

Certificates of Successful Completion are available for email, download and/or printing from your online account immediately following the successful completion of the post-test/evaluation.

**Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.

---

Nurses/Nurse Practitioners/Clinical Nurse Specialists - Credit Expired: 4/12/2019
No CE available for this board.

California Nurses: PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider #:17118 for 6.5 self-study contact hours.

You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Florida Nurses: PESI, Inc. is an approved provider by the Florida Board of Nursing. Provider #: FBN2858. These materials qualify for 6.5 self-study contact hours.

Iowa Nurses: PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 8.3 self-study contact hours.

Copies of the evaluation may be sent to the IBON. You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

---

Pharmacology Nurse Practitioners
This self-study program offers 415 instructional minutes of pharmacology content which is designed to qualify for 6.9 contact hours toward your pharmacology requirement.

---

Other Professions
This self-study activity qualifies for 6.75 clock hours of instructional content as required by many national, state and local licensing boards and professional organizations. Retain your certificate of completion and contact your board or organization for specific filing requirements.

Disclaimer: **Information obtained in this course should be used within your scope of practice.
**It is your ethical responsibility to report accurate hours to your licensing board.
**All self-study participants must complete and pass (80% or better) a post-test and evaluation prior to receiving a certificate of completion. If you require a copy of the test/evaluation for CE purposes, please print at the time you take the test. Or you may call our customer service department and a copy of your test/evaluation will be emailed to you. Please allow 30-45 days.

Nurses, Nurse Practitioners, Clinical Nurse Specialists, Other